With this mornings 4% rise at least you have two thirds of that Games. Any idea what is the driver of the rise? Typical that it rises today, i find it is much easier to time the buying than selling, I think it is something to do with the decision to buy in the first place still hangs over even though the numbers say sell. Have to push myself to sell.
Interesting article comparing to Fevertree, Britvic, Barr.
1. ROCE in slight decline due to 2015,16 acuisitions
2. Vimto not growing and still represents 77% of the business
3. UK represents 3/4 of business
4. Growth of late has largely been due to the 2 aquisitions
5. Saudi economic weakness has slowed growth - also blockage in Middle East
6. Despite share price decline the P/E is still up at 20 and seems still too high given the expectation os little or no growth, and perhaps too high for a trade buyer.
7. High ROCE, like Fevertree is largely due to outsourcing manufacturing, unlike Britvic and Barr
8. Quality control of manufacturers is a constant focus but so far has been good.
"I'm not sure I understand the rationale for this, but nontheless what about the similar hedging number for last year -- how does the 2016 number compare to the £87M in 2017?"
The corresponding figure was quite a bit higher - £157.5m at end FY2016 - but equally, gross debt (in sterling terms) was correspondingly higher. It's not that uncommon, and I think it correct to treat it as part of the true, underlying net debt calculation... it is a liquid "cash" asset, with a value readily realisable in the market, and though it will be volatile (eg. with FX movements), this will be matched and balanced by similar volatility in debt values when translated back to sterling. That is their point!
"On another point though it's worth considering the overall liabilities (as highlighted in my original version, albeit perhaps not considered a true net debt)... you will see that the tax liability, pension liabilities have improved, etc - resulting in an overall reduction in liabilities... The one consideration that is a concern, and granted this is only a transitory measurement, is that the receivables have improved £317.9M to £321.1M but the trade payables have jumped quite a bit..."
Yes, but this is a very different assessment, totally distinct from net debt considerations. And I am not sure it's particularly meaningful here, for a business with BVIC's characteristics... perhaps more so for one (eg. some engineering companies, aerospace etc) with much lumpier revenues and cashflows, with a small number of big individual contracts, and so on. But for many companies, elements like trade debtors and creditors are highly volatile figures which can swing wildly from period to period, even day to day... to repeat, a balance sheet is merely a snapshot on one particular moment in time, a lot of these figures could look very different if the date was struck even one week later.
Overall, IMHO, not time well spent to tie yourself in knots worrying about at least some of these movements here. Other than the point that, they do betray the positive overall working capital movement in FY2017... more often than not, this is more likely to reverse in the following period, or subsequently - yet FCF was relatively low again in FY2017, even with this benefit? It was my original negative point - not a source of massive concern, but something to keep a careful eye on.
"Still I think on balance Britvic has some pretty timeless brands now like J20, Fruit Shoot, Robinsons etc and they are in the unique position to sell Pepsi's products which despite a reduction in soda sales, have held up pretty well for the group."
Some good brands, yes... hardly timeless! Where was J20 and Fruit Shoot fifty, or even 20 years ago... and whither these 20 years from now? And the outlook for sugary, articificial "soft" drinks isn't exactly set fair - notwithstanding the undoubted strides towards much "healthier" products (it's all relative!)
As I said, I do see how you can justify a SP around 800p... no more, for me!
"... free cash flow has been consistently healthy and the dip in the free cash flow of late is explained quite well by the extra capital expenditure on plant, equipment and acquisitions... ROCE at Britvic has been consistently high over the years."
Ah, the old ROCE farrago... that seductive siren song, luring unsuspecting investors onto the rocks, to join the wreckage of Next, Capita and all the other stocks showing "consistently high" reported ROCE even as their SPs halve then plunge further from there...
Yes, return on capital employed matters, in the sense of true incremental returns... but you get little sense of this from "ROCE" data as commonly calculated, inevitably backward-looking as it is and always at the mercy of stated balance sheet values, which may or may not be at all meaningful to the investor of today, looking forward.
The clue here is that BVIC trades at over 6x market cap to stated Net Assets - in essence, telling us that the balance sheet values bear little relation to the true, current economic value of assets employed in the business. So showing high reported ROCE is pretty much meaningless - perhaps of some relevance to an investor who has been on the register for the duration, but only in telling him/her where they've been, not nearly so much about where they are going now. To the new investor buying in today, it is irrelevant, as they cannot "buy" this ROCE, they are having to pay a much higher price for the asset opportunity (some 6x, here) - what matters to them is the future returns on THEIR capital employed, not on some random and deeply historic figures on a balance sheet.
In simple terms, what matters are the returns BVIC now earns on this £60m spent on acquisitions last year, or the extra capex being ploughed in. Not so easy to say what these are now, and harder still what they will be going forward... Much easier to actually calculate an historic "ROCE" figure, but easier doesn't mean more helpful.
"Another point to note is :- ""... Britvic's earnings power value (EPV) explains nearly 90% of its current enterprise value - in other words not much future profits growth is being priced into the shares.""... OK we are two years on from 2015, and the share price is now 805, not 532, however, the point is still valid."
Yes, perhaps still valid as a point, but I would respectfully suggest, there's a world of difference as an investment assessment between 532p and 805p! It basically says BVIC was looking attractive on a risk/reward basis at 532p - as you yourself successfully concluded - but it doesn't tell me whether the shares are really worth £8, or perhaps £10, or maybe much nearer £6. And from HERE, I would say, that's a kinda important consideration - for both current and prospective new investors!
FWIW I think BVIC is not far off 'fair value' here - we can argue the toss over 25p or so either way. 15x P/E, 10-11x EV/EBITDA, a divi yield a bit below 3.5% - it's more or less a market-average rating... Not too demanding, particularly if you start looking at sector peers (but always beware the perils of pricing highly-rated stocks off of each other!) - but not sure I would want to pay any more than this. The low FCF yield is a big caveat for me - as you say, it might improve substantially if they start spending a lot less, but only time will tell if they will, and if they actually can...
"""No, I am talking about net debt rising from £416m to £503m - so a rise of £87m, of which only £60m can be explained away on acquisitions."""
""You then have £87m of derivatives hedging balance sheet debt""
I'm not sure I understand the rationale for this, but nontheless what about the similar hedging number for last year -- how does the 2016 number compare to the £87M in 2017?
On another point though it's worth considering the overall liabilities (as highlighted in my original version, albeit perhaps not considered a true net debt) and how they have compared -- so taking into account receivables and payables in each year.
If you incorporate the other liabilities you will see that the tax liability, pension liabilities have improved, etc - resulting in an overall reduction in liabilities from £1353.4 in 2016 to £1273.7 -- so moving in the right direction.
The one consideration that is a concern, and granted this is only a transitory measurement, is that the receivables have improved £317.9M to £321.1M but the trade payables have jumped quite a bit from £437.2M to £472.6M -- an increase of £35.4M or 8% -- I assume a lot of this is due to set up costs etc in South America under the new acquisitions and promotional launches -- (a guess).
Still I think on balance Britvic has some pretty timeless brands now like J20, Fruit Shoot, Robinsons etc and they are in the unique position to sell Pepsi's products which despite a reduction in soda sales, have held up pretty well for the group.
The opportunity, and the risk of course, is with all those folk down south of the Tijuana border.
"If anything the balance sheet has been strengthened between the two periods, as the short term "interest bearing loans and borrowings" have been reduced from £288.1M in 2016 to £89.7M in 2017. Albeit at the expense of the cash which has now hit £82.5M compared to £205.9M in 2016."
Yes, I wouldn't put any real weight on this - often it reflects a mere few weeks difference on maturity dates of short-term finance, etc, and the balance sheet values are only ever a snapshot on one particular day. You could strike a balance sheet date one week earlier, or later, and some of the figures might look very different.
For a business such as BVIC, with steady and relatively predictable gross cash generation, it is the overall underlying net debt picture which is by far the most important. And as I say, there is no real alarm here... ND/EBITDA stands around 2.1x, a decent level of leverage and you wouldn't want it massively higher, but for this kind of business, perfectly sustainable IMHO. Likewise interest cover (EBIT) at just over 9x.
"... but how are you calculating the net debt, it would help if you showed me what you are including in your figures to arrive at the numbers you quoted... Given the defacto formula for net debt as derived from this :-
""Net Debt = Short-Term Debt + Long-Term Debt - Cash and Cash Equivalents"" .."
Games - yes, in simple terms, that is indeed the operative formula. Taking the FY 2107 balance sheet figures for BVIC, you have £89.7m of short-term debt (in current liabilities), plus £582.7m debt in long-term liabilities, less the £82.5m of cash/equivalents - which nets off as £589.9m, in line with what they "report" as unadjusted net debt.
You then have £87m of derivatives hedging balance sheet debt (across both current and long-term assets, and further detailed in the notes to the accounts), which gives you the overall £503m of "adjusted" net debt, as reported. I am happy enough that this is the better and most "meaningful" figure, as the market value of the derivatives contracts will only go down with a corresponding fall (ie. due to FX movements) in sterling value of debt. But up to others to decide which figure to look to.
There is a further £7m of derivative (short and long-term) liabilities (£2.7m + £4.1m), which they don't count as hedging balance sheet debt... I'd have to dig around to determine exactly where they fit in, but it's pretty much de minimus for me.
It does highlight that Britvic's free cash flow has been consistently healthy and the dip in the free cash flow of late is explained quite well by the extra capital expenditure on plant, equipment and acquisitions.
He does make this comment worth noting :-
""""Spending money on new assets can help a company grow its profits in the future but it reduces cash flow in the short-term. Lower free cash flow isn't always a cause of concern as long as ROCE is holding up or improving. This is what has been happening at Britivic which is a good sign."""
ROCE at Britvic has been consistently high over the years.
Another point to note is :-
""Based on current 2015 EBIT staying the same forever, Britvic's earnings power value (EPV) explains nearly 90% of its current enterprise value - in other words not much future profits growth is being priced into the shares.""
OK we are two years on from 2015, and the share price is now 805, not 532, however, the point is still valid.
Unlike your Fevertree's and many other highly rated stocks in the FTSE 250 where EPV probably reflects the next 5-10 years of growth baked in and more in some cases.
If anything the balance sheet has been strengthened between the two periods, as the short term "interest bearing loans and borrowings" have been reduced from £288.1M in 2016 to £89.7M in 2017. Albeit at the expense of the cash which has now hit £82.5M compared to £205.9M in 2016.
The net assets are now up at £339.3m compared to £281M in 2016.
That's if you put much store in these figures -- at least it reduces the short term obligations which has to be a good thing should then merde hit the fan and the revenue dives.
"Bill where are you getting these numbers from and how are you calculating them?
I took mine from the actual numbers (albeit prelim) in this report, and ignored the adjusted stuff..."
Same source as you, Games, effectively - the preliminary results statement and accompanying financials, gives me everything I need at least 95% of the time. In this case, the debt situation is reported in the financial review (£503m "adjusted" net debt, or £590m ex-derivative hedges - I am agnostic which of these figures is the more meaningful), then you can cross-reference against the figures and accompanying notes to the balance sheet.
"... not inconceivable that they won't be acquiring anything next year, so there is your first £60+M and it's also unlikley that they will need to spend £139M again on new plant and buidings... A low cash flow cover is only a weakness is it's consistent and there isn't the business to cover it in the future.... revenues are fairly predictable to a degree and it's need to spend in excess of £200M next year ... is unlikely... "
Well, acquisition spend doesn't come into FCF considerations (or at least, shouldn't!) But beyond that, I generally agree, if FCF is depressed because of exceptionally high capex for a period, all well and good... as long as it is appropriate investment which will generate decent incremental future returns. But will it? Maybe, maybe not... little evidence of it thus far. And capex has been elevated - and FCF low (or even negative) for a few years now, as I recall... can they sustain their competitive position as and when capex levels return to more "normal" levels - if indeed they ever do?
"It's on the fence for me, as I've entered this at 529, so with the dividends and gains I'm up close to 40%."
So yes, I'm not saying it's a basket case, and it probably was cheap at 529p - as you have proved - and would be again. But at £8?? Not alarmingly expensive or anything, but not compelling overall, and actively underwhelming on a couple of metrics at least. And otherwise just raising a couple of key points which I think are valid questions for investors, maybe not outright concerns as yet, but certainly with the potential to become so.
""No, I am talking about net debt rising from £416m to £503m - so a rise of £87m, of which only £60m can be explained away on acquisitions. That was my original point...""
Bill where are you getting these numbers from and how are you calculating them?
I took mine from the actual numbers (albeit prelim) in this report, and ignored the adjusted stuff, which I tend to do now.
"""As things stand, they need to spend quite a lot less just to cover the dividend with FCF..."""
Well it's not inconceivable that they won't be acquiring anything next year, so there is your first £60+M and it's also unlikley that they will need to spend £139M again on new plant and buidings -- they look like they have done this all this year, hence the weak free cash flow.
A low cash flow cover is only a weakness is it's consistent and there isn't the business to cover it in the future. Looking at BVIC's business it's revenues are fairly predictable to a degree and it's need to spend in excess of £200M next year (this year even) is unlikley unless management decide there is another acquisition worth it's salt.
Games -- It's on the fence for me, as I've entered this at 529, so with the dividends and gains I'm up close to 40%.
"If we use :- Net Debt = (Short-Term Liabilities + Long-Term Liabilities) - Cash and Cash Equivalents... To 2nd Oct 2016 it stood at 1147.5... To 2nd Oct 207 it stood at 1191.7 -- an increase of 3.8% -- not sure this is classified as a big increase..."
Games - your formula doesn't give you net debt, you are mixing up various trade and other liabilities with actual financial liabilities. And fortunately so, you might say... don't think many would be comfortable with a business showing £1.2bn of net debt against trading profitability (EBIT) of notably under £200m...
No, I am talking about net debt rising from £416m to £503m - so a rise of £87m, of which only £60m can be explained away on acquisitions. That was my original point...
"Also looking at the cash flow statement :- £60.3M was due to acquisition costs, and £139M was due to purchase of property plant and equipment... interest payments on debt were £20M and dividends £64.9M... given that the acquisition and property costs should be much less next year, the cash flow should turn massively positive allowing a reduction in net debt by a large degree, and or a further increase in the dividend."
Again, not sure whence your confidence? I calculate free cash flow of £31m FY 2017 (does NOT include acquisition spend) - better than previous year, when it was actually negative, but still pretty paltry... a FCF yield no better than 1.5%, less than a third the UK market average, and nowhere near to covering the dividend (FCF cover 0.4x). And this was after quite a big working capital INFLOW, which can often reverse the following period... you'd normally expect big positive NWC to result in higher than normal FCF, not a surprisingly low figure...
I am not saying any of this is red-flag stage - as yet - with debt levels comfortable enough. But this is a business which is spending a lot of money, and has done for a while now, without necessarily delivering growth at a pace which you'd expect this super-normal spend to generate?
Sure, cash flow COULD turn "massively positive", as you call it - if they can get by with spending quite a lot less, and if underlying profits grow fast enough, and if working capital doesn't reverse again... or any reasonable combination thereof. But how much visibility and/or confidence in any of the above can we have? As things stand, they need to spend quite a lot less just to cover the dividend with FCF...
And it's not hard to find a good number of UK market peers - even within the same sector - where FCF cover is and has consistently been healthy (ie. 1.5-2x or more), and which offer decent FCF yields (ie. at least twice the BVIC level, and often a notably bigger multiple). And this was my ultimate point...
"""A big increase in net debt, materially more than can be explained by acquisition spend"""
Bill - Is this true, how are you calculating the net debt?
If we use :-
Net Debt = (Short-Term Liabilities + Long-Term Liabilities) - Cash and Cash Equivalents
To 2nd Oct 2016 it stood at 1147.5
To 2nd Oct 207 it stood at 1191.7 -- an increase of 3.8% -- not sure this is classified as a big increase.
Also looking at the cash flow statement :-
£60.3M was due to acquisition costs, and £139M was due to purchase of property plant and equipment resulting in a net cash outflow for the year of £188.5M when other factors are added back.
Cash flows for finance were £130M of which :-
The interest payments on debt were £20M and dividends £64.9M
The operating cash flow for the year were £198M and given that the acquisition and property costs should be much less next year, the cash flow should turn massively positive allowing a reduction in net debt by a large degree, and or a further increase in the dividend.
Unless of course the business in Brazil etc turns significantly south - but I'm guessing Simon Litherland sees a big growth opportunity in South America, hence the acquisitions.
"Revenues and dividend up, overall profit down but on one off costs. Like these figures and looks like a continuation of growth."
A big increase in net debt, materially more than can be explained by acquisition spend... and then you have, once again, pretty paltry free cash flow generation (on a true cash basis, rather their own "adjusted" definition). Better than the previous year (when FCF was negative), but still very underwhelming - with FCF dividend cover down at 0.4x.
This was be my biggest caveat here... otherwise, underlying growth is okay, but pretty pedestrian. Not sure why the market is so impressed, perhaps expectations had been suitably beaten down?
The shares are not expensive relative to peers, perhaps, but hardly cheap relative to alternative equivalent stock opportunities across the UK market.
Games- I was cautious after yesterday. I thought UDG numbers were fine but the market did not agree. They are up over 200% since I invested so a 5% fallback was not a worry but hence my caution today. There is no comparison between the two businesses but market reaction can be a fickle thing.
Time to sell. Another share of mine that's had a good run over the past 9 months since buying. I can't see this rising a great deal further as it always seems to get stuck in the 700s before tumbling down again. Good luck to holders.
This is an extract from the article, but it's better if you look at the graphs :-
"""""I find this a simple and very useful exercise to weigh up the valuations of companies. Forget about speculating on future share prices, just look at a company from the position of owning it outright and what you might get back in return.
To do this, just turn the current PE ratio upside down and divide the current EPS by the current share price to get the earnings yield. So for Britvic divide 49p by 692p to get an earnings yield of 7.1%. Fevertree's earnings yield is 1.4%.
If you invest £100 in both businesses, you will currently get £7.10 per year in profits from Britvic and £1.40 from Fevertree.
But Fevertree is expected to grow its profits at a much faster rate than Britvic. At the moment it is expected to grow its EPS this year by around 15%. Britvic will struggle to grow by 3%.
Now let's assume that Fevertree can grow its profits by 15% per year for the next ten years - a much higher sustained growth rate than is currently expected - and that Britvic plods along at a pedestrian 3%.
Despite a vastly superior growth rate, after ten years an investor would be getting £4.90 a year from Fevertree and £9.30 from Britvic. A Britvic investor would have pocketed a cumulative £81.40 in profits compared to £28.40 from Fevertree.
If Fevertree grew it profits by 20% a year, an investor would have £7.20 per year at the end of year ten, or about the same as they would get from Britvic now. They would collect £36.34 in cumulative profits - less than half the amount collected by an investor in Britvic.""""""
Look beyond the sugar tax to see Britvics true potential as a major global player:
The middle weekend of Wimbledon fortnight is a high point in Britvics marketing calendar. All those gratuitous shots of Robinsons on Centre Court; all those thirsts that must be quenched after some heart-stopping rallies. At 83 years, Robinsons possesses the second-longest Wimbledon brand tie-up after Slazenger. Yet just because the squash remains synonymous with summer tennis doesnt always translate into rising sales.
In fact Britvics so-called stills division including Robinsons, J20 and Fruit Shoot has been the laggard of late, with sales declining 2.6% in the half year figures released in May. In an attempt to cope with rising costs, Simon Litherland, the chief executive, has aimed to put value ahead of volume to protect profitability. He reported Robinsons had returned to volume growth thanks partly to the success of Squashd, the brands super concentrate pouch. There was better news from its carbonates division, where Pepsi, led by the Pepsi Max variety, grew revenue and gained market share.
Britvic has been Pepsis sole bottling partner in the UK for 30 years. The arrangement also covers 7UP and Mountain Dew. Both sides are at pains to say it continues to be business as usual even though PepsiCo is selling its 4.5% stake in Britvic.
For the third quarter trading update due on July 27, analysts at Jefferies have pencilled in 4.4% underlying growth in group revenues. That would mark an acceleration from 3.7% at the half year and is thanks in part to better weather this June. Like Wimbledon before the retractable roof, rain really does stop play in this category. A good summer is worth as much as £5 million.
Even without consulting the weather, investors like what they see. Britvic shares have bubbled up 24% so far this year. They have further to go. At 13 times next years forecast earnings, the stock trades at a sharp discount to rivals AG Barr and Vimto maker Nichols.
There is uncertainty ahead, but Britvics portfolio and geographic spread mean it is well positioned to quench shareholders thirst for value. Questor says Buy. (at 709.5p)"
"Even without consulting the weather, investors like what they see. Britvic shares have bubbled up 24pc so far this year. They have further to go. At 13 times next years forecast earnings, the stock trades at a sharp discount to rivals AG Barr and Vimto maker Nichols. There is uncertainty ahead, but Britvics portfolio and geographic spread mean it is well positioned to quench shareholders thirst for value. Buy."
"Has the 2017 rebound in mid-cap soft-drinks stock LSE:BVIC:BritvicÂ reached fair value, or is there further upside? It is also a study in the extent to trust brokers' targets or take a contrarian view.Last January, at 585p, I drew attention to ..."
(Reuters) - Sales of soda drinks decreased about 1.2 percent in the United States in 2016, falling for the 12th year in a row, a report by trade publication Beverage Digest showed, as demand was hit by consumer choosing healthier options and a slew of sugar taxes aimed at stemming obesity and diabetes.
1.2% is a pretty big drop in one year.
Does Britvic have enough non soda (no, low) sugar products to compensate for this?
Games -- will reconsider holding around the 700+p level
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.